Friday 6 November 2026 Export TMO’s income statement to Excel — free account

Thermo Fisher Scientific Inc.

Thermo Fisher Scientific Inc.’s revenue for fiscal 2025 (year ended December 2025) was $44.6 billion, up 3.91% from fiscal 2024.

Revenue: +9.13%
EPS: +8.64%
Free cash flow: +15.0%
Total debt: +22.8%

Quarter to September 2026, against a year earlier

693.01 16.07 +2.37%

Follow TMO

Alert me

Market cap: $250.8B
P/E: 35.8×
Fwd P/E: 35.7×
Dividend yield: 0.27%
F-score: 5/9
Altman Z: 3.84
Beneish M: −2.46
Dividend safety: 88/100

Overview Business Profile Earnings & Analysis Segments Valuation Filings

Thermo Fisher Scientific Inc. 10-Q filed Oct 30, 2026

Fiscal Q3 2026 · Period ended Sep 26, 2026 · Filed Oct 30, 2026 · accepted 10:52 AM ET · Document on sec.gov · Filing index

What changed

Part I, Item 2, Management’s Discussion and Analysis Part II, Item 1A, Risk Factors

Previous quarter Same quarter last year

Part I, Item 2, Management’s Discussion and Analysis, against the 10-Q filed Oct 31, 2025: 22 added · 14 removed · 28 modified; 4 with only figures updated; 6 moved without change

Thermo Fisher Scientific Inc. 10-Q filed Oct 30, 2026

What changed

Stockrow Weekly